<DOC>
	<DOCNO>NCT02164058</DOCNO>
	<brief_summary>The purpose study determine device know TandemHeart® System ( TandemHeart ) help limit heart damage reduce serious complication certain type heart attack ( acute ST elevation anterior wall myocardial infarction [ STEMI ] ) evaluate use TandemHeart system prior procedure call percutaneous coronary intervention ( PCI )</brief_summary>
	<brief_title>TandemHeart Reduce Infarct Size ( TRIS Trial )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>INCLUSION CRITERIA The following list general inclusion criterion . More detailed information find study protocol . 1 . ≥ 18 year age 2 . Presents within 6 hour acute MI symptom 3 . Evidence ST elevation 4 . First myocardial infarction 5 . Written inform consent EXCLUSION CRITERIA The following list general exclusion criterion . More detailed information find study protocol . 1 . Contraindications antiplatelet/anticoagulation therapy 2 . History blood disorder active bleed 3 . Renal dysfunction failure 4 . Neurologic damage 5 . Cardiogenic shock 6 . History cerebrovascular disease 7 . History transfusion reaction 8 . Prior coronary artery bypass surgery 9 . Participation another trial investigational drug device 10 . Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Myocardial infarction</keyword>
	<keyword>STEMI</keyword>
	<keyword>ST elevation MI</keyword>
	<keyword>Acute MI</keyword>
</DOC>